954P Cemiplimab with platinum-based chemotherapy (chemo) for first-line (1L) locally advanced non-small cell lung cancer (laNSCLC): EMPOWER-Lung 3 subgroup analysis
- Resource Type
- Abstract
- Authors
- Kalinka-Warzocha, E.; Gogishvili, M.; Makharadze, T.; Dvorkin, M.; Penkov, K.D.; Laktionov, K.; Nechaeva, M.; Rozhkova, I.; He, X.; Quek, R.; Pouliot, J-F.; Seebach, F.; Lowy, I.; Gullo, G.; Rietschel, P.
- Source
- In Annals of Oncology September 2022 33 Supplement 7:S983-S984
- Subject
- Language
- ISSN
- 0923-7534